Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2016 - 2025)

Catalyst Pharmaceuticals' Other Working Capital Changes history spans 16 years, with the latest figure at $476000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 94.58% year-over-year to $476000.0; the TTM value through Dec 2025 reached $177000.0, down 97.92%, while the annual FY2024 figure was $11124.0, 99.81% down from the prior year.
  • Other Working Capital Changes reached $476000.0 in Q4 2025 per CPRX's latest filing, up from -$686000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $11.1 million in Q2 2024 to a low of -$11.3 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $509450.0, with a median of -$75000.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: surged 2307.79% in 2023, then crashed 7787.64% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$77000.0 in 2021, then soared by 448.05% to $268000.0 in 2022, then crashed by 632.46% to -$1.4 million in 2023, then soared by 715.21% to $8.8 million in 2024, then plummeted by 94.58% to $476000.0 in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Other Working Capital Changes are $476000.0 (Q4 2025), -$686000.0 (Q3 2025), and $7.4 million (Q2 2025).